Finance

Lists
GANX:NASDAQ
Gain Therapeutics Inc
US$ २.१२
-२.०८%
(-०.०४५) 1D
US$ २.१६
+१.८९% (+०.०४०)
After hours
Closed: अगस्ट १४, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
US$ २.१६
High
US$ २.१९
Low
US$ २.०९
Mkt. cap
९.२३ करोड
Avg. vol.
६.२६ लाख
Volume
५.१९ लाख
52-wk high
US$ ४.३४
52-wk low
US$ १.५१
EPS
-US$ ०.५१
Beta
०.१९
Shares outstanding
४.३६ करोड
No. of employees
२१
Open
US$ २.१६
High
US$ २.१९
Low
US$ २.०९
Mkt. cap
९.२३ करोड
Avg. vol.
६.२६ लाख
Volume
५.१९ लाख
52-wk high
US$ ४.३४
52-wk low
US$ १.५१
EPS
-US$ ०.५१
Beta
०.१९
Shares outstanding
४.३६ करोड
No. of employees
२१
News stories
From web sources and news partners
https://www.dars.gov.et/
https://www.dars.gov.et/
·
१ महिना पहिले
Gain Therapeutics (GANX) Declines 4% as Biotech Stock Tests Key Support - NAAIM Leverage
About Gain Therapeutics Inc
CEO-
Employees२१
Founded२०१७
Headquarters-
Sector-
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current US$ २.१२
US$ ८.०० (+२७७.३६%)
Average
US$ ७.२० (+२३९.६२%)
Lowest
US$ ५.०० (+१३५.८५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ७.००
+२३०.२%
08/13/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
US$ ८.००
+२७७.४%
08/13/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ ५.००
+१३५.८%
08/11/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$ ८.००
+२७७.४%
07/01/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ८.००
+२७७.४%
07/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
२८.१२ लाख
२३.१६ लाख
२७.४१ लाख
-
Cost of revenue
२८.१२ लाख
२३.१६ लाख
२७.४१ लाख
-
Research and development expenses
-
-
-
२१.३८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१९.७९ लाख
२१.५५ लाख
२६.१२ लाख
२५.४३ लाख
Operating expense
१९.७९ लाख
२१.५५ लाख
२६.१२ लाख
४६.८२ लाख
Total operating expenses
४७.९१ लाख
४४.७१ लाख
५३.५४ लाख
४६.८२ लाख
Operating income
-४७.९१ लाख
-४४.७१ लाख
-५३.५४ लाख
-४६.८२ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-४७.३५ लाख
-४४.६७ लाख
-५४.२६ लाख
-४५.७२ लाख
EBT excluding unusual items
-४७.३५ लाख
-४४.६७ लाख
-५४.२६ लाख
-४५.७२ लाख
Income tax expense
५.४९ लाख
७०.१२ हजार
१.८३ लाख
१.०४ लाख
Effective tax rate
-११.६०%
-१.५७%
-३.३७%
-२.२८%
Other operating expenses
-
-
-
-
Net income
-५२.८४ लाख
-४५.३८ लाख
-५६.०९ लाख
-४६.७६ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.१५
-०.११
-०.१३
-०.११
Interest and investment income
८३.३० हजार
८८.५८ हजार
९३.३४ हजार
६१.०६ हजार
Interest expense
-
-
-
-
Net interest expenses
८३.३० हजार
८८.५८ हजार
९३.३४ हजार
६१.०६ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-४७.८० लाख
-४४.५६ लाख
-५३.४५ लाख
-४६.४२ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू